Abbreviations: FGR, fetal growth restriction; MVM, maternal vascular malperfusion; SGA, small-for-gestational age; VUE, villitis of unknown etiology. 
| INTRODUC TI ON
Fetal growth restriction (FGR) implies failure of a fetus to achieve its growth potential and is associated with perinatal and long-term mortality and morbidity. [1] [2] [3] [4] [5] [6] However, given the difficulty in determining the growth potential of the individual fetus, FGR is commonly defined as sonographic estimated fetal weight or abdominal circumference below the 10th percentile for gestational age.
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Placental dysfunction is the most common etiology of FGR. 1, 8, [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] The most common placental findings in pregnancies complicated by FGR are lesions reflective of maternal vascular malperfusion (MVM) pathology, although other pathologies such as fetal vascular malperfusion and chronic villitis have been associated with FGR as well. 10, 11, 13, 15, 16, [20] [21] [22] In recent years, it has been suggested that early and late FGR may represent two distinct entities. Early FGR is often associated with preeclampsia, abnormal umbilical artery Doppler findings and poor perinatal outcomes. In contrast, late FGR is associated with a milder degree of placental dysfunction and is less likely to be associated with preeclampsia and changes in umbilical artery Doppler. 1, 23, 24 However, the optimal gestational age cut-off that differentiates these two phenotypes of FGR is currently unclear and has been arbitrarily set in previous studies at between 32 and 37 weeks. 1, 2, 10, 15, 18, 19, [23] [24] [25] [26] [27] More recently, Savchev et al attempted to establish the cut-off using a composite neonatal outcome and a decision tree analysis technique; they identified 32 0/7 weeks at the time of diagnosis as the optimal gestational age cut-off. 28 This cut-off has been supported recently in a consensus statement based on a Delphi procedure. 29 Given that the pathogenesis of early and late FGR may differ, we hypothesized that placental pathology, as a more direct measure of the pathogenesis of FGR, will be valuable in providing insight into the placental mechanism involved in early vs late FGR and in determining the optimal gestational age cut-off that differentiates between these two phenotypes. However, data on the placental findings in early vs late FGR are limited, 12, 15, 18, 25 and the interpretation of available studies is also limited by small sample size. In addition, we were unable to identify studies that attempted to determine the optimal gestational age cut-off based on placental pathology.
Thus, in the current study, we aimed to determine whether the distinction between early and late FGR is supported by differences in placental pathology and to test the hypothesis that placental pathology findings can be used to identify the gestational age cut-off that differentiates early from late FGR.
| MATERIAL AND ME THODS
We conducted a retrospective cohort study of all women with singleton neonate diagnosed as small-for-gestational age (SGA), defined as birthweight below the 10th percentile for gestational age according to a sex-specific Canadian birthweight reference, 30 who gave birth in a tertiary referral center between January 2001 and December 2015. We excluded pregnancies complicated by any of the following conditions: multifetal gestation, gestational age at birth less than 26 0/7 weeks (due to the small number of cases available below that gestational age), fetal major congenital or genetic fetal anomalies and missing data regarding placental pathology.
Cases were identified using the institutional perinatal database, and the medical records of eligible women were reviewed for the following data: demographic and obstetric characteristics, validation of gestational age by first-trimester sonography, complications during pregnancy, gestational age at birth, birthweight and short-term neonatal outcomes.
According to our departmental policy, all placentas of pregnancies complicated by SGA are routinely sent for pathological examination. The placental pathology reports of all women who met the inclusion criteria were reviewed in detail for the following information: placental weight, placental weight percentile for gestational age based on the nomograms of Almog et al, 31 and macroscopic and histologic abnormalities of the placenta and umbilical cord.
| Classification of placental findings
Placental pathology examinations were performed using a standard protocol as previously described. 32 In brief, placental weight was de- Hyper-or hypocoiling is defined as >0.3 coil/cm or <0.1 coil/cm, respectively). 33 At least four samples from each placenta were embedded in paraffin blocks for microscopic assessment. Samples were obtained from membranes, umbilical cord, centrally and marginally located tissue that appeared abnormal on gross examination, and up to three samples from normally appearing placental tissue. villositis. For the purpose of the current study, we reviewed only the pathology reports and not the actual specimens, and classified them according to the classification noted above; therefore, the pathologists were blinded to the hypothesis of the current study.
| Statistical analyses
To identify the gestational age cut-off between early and late FGR,
we analyzed the prevalence of macroscopic and microscopic placental abnormalities as a function of gestational age at birth. Once a potential gestational age cut-off was identified, we compared the rate of placental pathologies before and after this cut-off. To eliminate placental changes attributed to hypertensive disorders, the analysis The statistical analysis was performed using SPSS version 24.0 (IBM Corp., Armonk, NY, USA). Differences were considered significant at P < 0.05.
| Ethical approval
The current study was approved by the Sunnybrook Health Sciences
Center, Research Ethics Board (#353-2014, approved 23 September 2014).
| RE SULTS

| Characteristics of study population
A total of 55 431 singleton neonates were born during the study period, of whom 4675 (8.4%) were SGA and 895 (1.6%) met the inclusion criteria (Figure 1 ). The characteristics of the study population are presented in Table 1 . The rate of hypertensive disorders was 26.0% and the rate of severe SGA (birthweight <5th percentile) was 51.8%.
| Macroscopic placental findings
The rate of macroscopic placental findings by gestational week at birth is presented in Figure 2 . The rate of abnormal placental cord insertion decreased with gestational age, whereas the rate of hypercoiled umbilical cord increased with gestational age in a continuous manner, so that no clear gestational age cut-off could be identified Values presented as mean (± SD) or n (%). NICU, neonatal intensive care unit.
for these abnormalities. The rate of placental weight <10th percentile for gestational age and single umbilical artery remained relatively stable throughout gestation (Figure 2 ).
| Histological placental findings
The rate of histological placental findings by gestational week at birth is presented in Figure 3 . The only pathology that changed with gestational age was MVM, which decreased in frequency with increasing gestational age birth; the rate of fetal vascular malperfusion pathology, chronic villitis and hemorrhage remained stable throughout gestation.
We therefore decided to focus the rest of the analysis on MVM.
Given that individual MVM lesions might be nonspecific and are often seen in uncomplicated pregnancies, we analyzed the rate of multiple MVM lesions (≥2 or ≥3 MVM lesions) by gestational week at birth (Figure 4 97.4% vs 89.1%, P = 0.02 for ≥1 MVM lesions; 84.6% vs 33.4%, P < 0.001 for ≥2 MVM lesions; and 43.6% vs 5.2%, P < 0.001 for ≥3 MVM lesions ( Figure 5 ).
To eliminate placental findings that might be attributed to hypertensive disorders which often accompany FGR, we repeated the analysis in the subgroup of women without chronic hypertension, gestational hypertension or preeclampsia (ie, isolated SGA, n = 662) ( Figure 6 ). While the rate of ≥1 MVM lesions was not significantly different before and after 33 0/7 weeks' gestation (87.3% vs 82.1%, P = 0.27), the rate of ≥2
MVM lesions and ≥3 MVM remained significantly higher before than after 33 0/7 weeks even in this subgroup of women with isolated SGA (59.2% vs 23.9%, P < 0.001 and 25.4% vs 3.0%, P < 0.001, respectively).
To address the clinical correlation of this placental pathology-based cut-off, we compared the clinical characteristics and pregnancy outcomes of women who gave birth before and after 33 0/7 weeks' gestation ( Table 2 ). Women in the early group (less than 33 0/7 weeks) were younger, had higher rates of chronic hypertension, gestational hypertension or preeclampsia, cesarean delivery, intrauterine fetal death, 5-minute Apgar score <7 and admission to the neonatal intensive care unit (Table 2 ).
| D ISCUSS I ON
In the current study, we aimed to identify the optimal gestational age cut-off that differentiates early from late FGR using placental pathology. Based on the drop in the rate of MVM lesions, we identified 33 0/7 weeks of gestation at birth as the optimal cut-off. This F I G U R E 2 Rate of macroscopic placental abnormalities by gestational week at birth in pregnancies complicated by small-for-gestational age (SGA, defined as birthweight <10th percentile for gestational age) [Color figure can be viewed at wileyonlinelibrary.com] observation held true for the entire cohort, as well as for the subgroup of neonates with severe SGA and in cases of isolated SGA. We did not find any obvious differences in other placental abnormalities.
The rationale for the distinction between early and late FGR is based on reported differences in presentation, Doppler findings, natural history, associated hypertensive complications, prognosis and possibly the underlying mechanisms. 36 However, data on the placental findings in cases of early vs late FGR, which may provide insight into the mechanisms involved in each of these phenotypes, are limited.
Kovo et al compared the placental pathology findings in women
with a normotensive pregnancy who gave birth to an SGA infant at 34 weeks' gestation or less (early SGA, n = 24) with those who gave birth to an SGA infant at more than 34 weeks' gestation (late SGA, n = 334). In agreement with our findings, they reported a higher rate of MVM lesions in the early-vs late-SGA group (83.3% vs 60%).
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However, they did not attempt to identify the optimal gestational age cut-off between the two conditions.
Although multiple investigators have studied early and late FGR separately, we were only able to identify a few studies that focused on determining the gestational age cut-off between the two conditions. Savchev et al 28 attempted to define the gestational age cut-off between early and late SGA based on a decision-analysis model derived from clinical outcomes; they identified 32 weeks at the time of diagnosis as the optimal threshold. However, it should be emphasized that that threshold resulted in a significant overlap in the rate of placental findings between early and late FGR (rate of MVM lesions 58.6% vs 40.9% in the early and late SGA groups, respectively). In addition, the fact that the rate of MVM lesions in our study was considerably higher (93.1% vs 83.4%, respectively) may suggest that our cohort is more likely to represent cases of true FGR rather than constitutional SGA. More recently, a consensus panel on the definition of FGR using a Delphi procedure 29 supported the use of 32 weeks as the optimal cut-off. Interestingly, approximately 40% of the experts initially supported 34 weeks as the optimal threshold, highlighting the uncertainty and the lack of clear evidence regarding the optimal cut-off.
The current study has several limitations. First, given the retrospective design it was not possible to blind the pathologist to the indication for placental assessment (ie, suspected FGR, with or without hypertensive disorder of pregnancy). However, it should be emphasized that the pathologists were blinded to the hypothesis of the current study. In addition, due to the retrospective design we lacked information on certain variables such as smoking status, ethnicity, body mass index and Doppler findings. We also could not assess the periviable group (less than of SGA was made after birth, when the placenta was no longer available. When analyzed, it was found that compared with the pregnancies presented in this cohort, the gestations with missing pathology were similar in terms of demographics but were less likely to be complicated by GDM (1.6% vs 6.3%, P < 0.001), placental abruption (0.3% vs 2.0%, P < 0.001), chronic hypertension (1.9% vs 0.9%, P = 0.009) and hypertensive disorders of pregnancy (4.3% vs 26.0%, P < 0.001). The rate of preterm birth also differed between the groups, with a lower rate observed among the patients with missing data (PTB less than 34 weeks: 1.7% vs 17.9%, P < 0.001; PTB less than 32 weeks: 1.1% vs 13.3%, P < 0.001). On the one hand, these differences may suggest that our cohort is not representative of all (unselected) SGA fetuses.
On the other hand, these differences also emphasize the fact that our cohort is more likely to represent cases of true FGR that were diagnosed antenatally, and that placental pathology is more representative of FGR, and thus more reproducible and generalizable. Additionally, several previous reports discussed the higher incidence of MVM lesions in spontaneous preterm birth.
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Since our analysis focused on SGA alone, and not on low-risk spontaneous preterm births, and since we do not have data on whether the birth was spontaneous or iatrogenic, we could not control for this factor. Nonetheless, from the numbers in Table 2 it can be seen that the early SGA group had a 59.2% rate of preeclampsia/gestational hypertension (compared with 15.9% in the late group) and a cesarean delivery rate of 91.4% (vs 42.4% in the late group)-both of which suggest a higher likelihood of iatrogenic preterm birth than spontaneous birth. Finally, the cut-off identified in the current study is based on gestational age at birth rather than on gestational age at the time of diagnosis. Although it has been argued that the cut-off should be based on gestational age at the time of diagnosis rather than on gestational age at birth (as the latter in not known in women with antenatally suspected FGR), 28 it should be recognized that gestational age at diagnosis is highly dependent on the antenatal protocols (including frequency of antenatal visits and ultrasound exams) and thus in many cases it does not truly reflect the actual timing of onset of FGR. Indeed, other investigators have also used gestational age at birth to define late FGR. 
| CON CLUS ION
In summary, we found that the distinction between early and late FGR is supported by placental pathology and that using placental pathology as a direct measure of the mechanisms underlying FGR, the optimal gestational age at birth cut-off that differentiates early from late FGR is 33 0/7 weeks of gestation. These findings support the concept that early and late FGR are distinct entities that differ not only in the clinical characteristics but also in the underlying pathogenetic mechanisms.
These data may aid clinicians in decision-making regarding proper surveillance protocols for FGR including frequency of follow-up visits, ultrasound and Doppler studies, timing of corticosteroids, etc. Future prospective studies should confirm these findings and correlate placental pathology with Doppler findings and angiogenic factors.
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TA B L E 2 Outcomes of pregnancies with early vs late small-for-gestational age (SGA)
